Amer Bio Revenue vs. EBITDA
| ABMCDelisted Stock | USD 0.01 0 38.00% |
For Amer Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Amer Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Amer Bio Medica utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Amer Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Amer Bio Medica over time as well as its relative position and ranking within its peers.
Amer |
Amer Bio Medica EBITDA vs. Revenue Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Amer Bio's current stock value. Our valuation model uses many indicators to compare Amer Bio value to that of its competitors to determine the firm's financial worth. Amer Bio Medica is the top company in revenue category among its peers. It also is number one stock in ebitda category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Amer Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Amer Bio's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Amer Revenue vs. Competition
Amer Bio Medica is the top company in revenue category among its peers. Market size based on revenue of Health Care industry is presently estimated at about 1.37 Billion. Amer Bio adds roughly 2.22 Million in revenue claiming only tiny portion of equities under Health Care industry.
Amer EBITDA vs. Revenue
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Amer Bio |
| = | 2.22 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Amer Bio |
| = | (199 K) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Amer EBITDA Comparison
Amer Bio is currently under evaluation in ebitda category among its peers.
Amer Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Amer Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Amer Bio will eventually generate negative long term returns. The profitability progress is the general direction of Amer Bio's change in net profit over the period of time. It can combine multiple indicators of Amer Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York. Amer Bio operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 32 people.
Amer Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Amer Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Amer Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Amer Bio's important profitability drivers and their relationship over time.
Use Amer Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Amer Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amer Bio will appreciate offsetting losses from the drop in the long position's value.Amer Bio Pair Trading
Amer Bio Medica Pair Trading Analysis
The ability to find closely correlated positions to Amer Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Amer Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Amer Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Amer Bio Medica to buy it.
The correlation of Amer Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Amer Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Amer Bio Medica moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Amer Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Amer Bio position
In addition to having Amer Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Sector ETFs Thematic Idea Now
Sector ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Sector ETFs theme has 439 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Sector ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Consideration for investing in Amer Pink Sheet
If you are still planning to invest in Amer Bio Medica check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Amer Bio's history and understand the potential risks before investing.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |